The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
T cell response to SARS-CoV-2 infection in humans: A systematic review
Open accessAbstract
Background: Understanding the T cell response to SARS-CoV-2 is critical to vaccine development, epidemiological surveillance and disease control strategies. This systematic review critically evaluates and synthesises the relevant peer-reviewed and pre-print literature published from 01/01/2020-26/06/2020. Methods: For this systematic review, keyword-structured literature searches were carried out in MEDLINE, Embase and COVID-19 Primer. Papers were independently screened by two researchers, with arbitration of disagreements by a third researcher. Data were independently extracted into a pre-designed Excel template and studies critically appraised using a modified version of the MetaQAT tool, with resolution of disagreements by consensus. Findings were narratively synthesised. Results: 61 articles were included. 55 (90%) studies used observational designs, 50 (82%) involved hospitalised patients with higher acuity illness, and the majority had important limitations. Symptomatic adult COVID-19 cases consistently show peripheral T cell lymphopenia, which positively correlates with increased disease severity, duration of RNA positivity, and non-survival; while asymptomatic and paediatric cases display preserved counts. People with severe or critical disease generally develop more robust, virus-specific T cell responses. T cell memory and effector function has been demonstrated against multiple viral epitopes, and, cross-reactive T cell responses have been demonstrated in unexposed and uninfected adults, but the significance for protection and susceptibility, respectively, remains unclear. Conclusion: A complex pattern of T cell response to SARS-CoV-2 infection has been demonstrated, but inferences regarding population level immunity are hampered by significant methodological limitations and heterogeneity between studies, as well as a striking lack of research in asymptomatic or pauci-symptomatic individuals. In contrast to antibody responses, population-level surveillance of the T cell response is unlikely to be feasible in the near term. Focused evaluation in specific sub-groups, including vaccine recipients, should be prioritised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–251 of 251
Heidepriem, J., Dahlke, C., Kobbe, R., Santer, R., Koch, T., Fathi, A., Seco, B. M. S., Ly, M. L., Schmiedel, S., Schwinge, D., et al. (2021) · Pathogens · doi:10.3390/pathogens10040438 · Cited by 64
Fung, M., Chiu, C. Y., DeVoe, C., Doernberg, S. B., Schwartz, B. S., Langelier, C., Henrich, T. J., Yokoe, D. S., Davis, J. A., Hays, S. R., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16079 · Cited by 63
Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID‐19
Ni, M., Tian, F., Xiang, D., & Yu, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26070 · Cited by 63
Madariaga, M. L. L., Guthmiller, J. J., Schrantz, S. J., Jansen, M. O., Christensen, C., Kumar, M., Prochaska, M., Wool, G. D., Celauro, A. D., Oh, W. H., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13185 · Cited by 63
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting
Müller, L., Ostermann, P. N., Walker, A., Wienemann, T., Mertens, A., Adams, O., Andrée, M., Hauka, S., Lübke, N., Keitel, V., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04169-7 · Cited by 59
Antibody Profiles in Mild and Severe Cases of COVID-19
Liu, Z., Liu, Y., Wan, L., Xiang, T.-X., Le, A., Liu, P., Peiris, M. J. S., Poon, L. L. M., & Zhang, W. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa137 · Cited by 57
Humoral Immune Response to SARS-CoV-2
Herroelen, P. H., Martens, G. A., Smet, D. D., Swaerts, K., & Decavele, A.-S. C. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa140 · Cited by 57
Liu, B., Han, J., Cheng, X., Yu, L., Zhang, L., Wang, W., Ni, L., Wei, C., Huang, Y., & Cheng, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-73955-8 · Cited by 55
Protective humoral immunity in SARS-CoV-2 infected pediatric patients
Zhang, Y., Xu, J., Jia, R., Yi, C., Gu, W., Liu, P., Dong, X., Zhou, H., Shang, B. Z., Cheng, S., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0438-3 · Cited by 54
Marcos‐Jiménez, A., Sánchez‐Alonso, S., Alcaraz‐Serna, A., Esparcia, L., López‐Sanz, C., Sampedro-Nuñez, M. A., Mateu‐Albero, T., Sánchez‐Cerrillo, I., Martínez‐Fleta, P., Gabrie, L., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048858 · Cited by 52
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
Agarwal, V., Venkatakrishnan, A., Puranik, A., Kirkup, C., Lopez-Marquez, A., Challener, D. W., Theel, E. S., O’Horo, J. C., Binnicker, M. J., Kremers, W. K., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00375-y · Cited by 51
Sandri, M. T., Azzolini, E., Torri, V., Carloni, S., Pozzi, C., Salvatici, M., Tedeschi, M., Castoldi, M., Mantovani, A., & Rescigno, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91773-4 · Cited by 49
Yang, H. S., Racine‐Brzostek, S., Lee, W. T., Hunt, D., Yee, J. K., Chen, Z., Kubiak, J. M., Cantu, M. D., Hatem, L., Zhong, E., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.004 · Cited by 46
Giménez, E., Albert, E., Torres, I., Remigia, M. J., Alcaráz, M. J., Galindo, M. J., Blasco, M. L., Solano, C., Forner, M. J., Redón, J., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26213 · Cited by 46
SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality
Bryan, A. B., Fink, S. L., Gattuso, M. A., Pepper, G., Chaudhary, A., Wener, M. H., Morishima, C., Jerome, K. R., Mathias, P. C., & Greninger, A. L. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa535 · Cited by 46
Edouard, S., Colson, P., Melenotte, C., Pinto, F. D., Thomas, L., Scola, B. L., Million, M., Tissot‐Dupont, H., Gautret, P., Stein, A., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04104-2 · Cited by 43
Houlihan, C. F., Vora, N., Byrne, T., Lewer, D., Heaney, J., Moore, D., Matthews, R., Adam, S., Enfield, L., Severn, A., et al. (2020) · medRxiv · doi:10.1101/2020.06.08.20120584 · Cited by 42
Shields, A. M., Faustini, S. E., Pérez-Toledo, M., Jossi, S. E., Allen, J. D., Al‐Taei, S., Backhouse, C., Dunbar, L., Ebanks, D., Emmanuel, B., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000872 · Cited by 40
Self-citationMontenegro, P., Brotons, C., Serrano, J., Fernández, D., Garcia-Ramos, C., Ichazo, B., Lemaire, J., Moral, I., Wienese, R. P., Pitarch, M., et al. (2020) · Family Practice · doi:10.1093/fampra/cmaa096 · Cited by 37
SARS-CoV-2 IgG antibody responses in New York City
Reifer, J., Hayum, N., Heszkel, B., Klagsbald, I., & Streva, V. A. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115128 · Cited by 35
Huang, J., Mao, T., Li, S., Wu, L., Xu, X., Li, H., Xu, C., Su, F., Dai, J., Shi, J., et al. (2020) · medRxiv · doi:10.1101/2020.04.22.20071258 · Cited by 34
A possible role of immunopathogenesis in COVID-19 progressionPreprint
Anft, M., Paniskaki, K., Blazquez‐Navarro, A., Doevelaar, A., Seibert, F. S., Hoelzer, B., Skrzypczyk, S., Kohut, E., Kurek, J., Zapka, J., et al. (2020) · medRxiv · doi:10.1101/2020.04.28.20083089 · Cited by 34
Cohen, R., Jung, C., Ouldali, N., Sellam, A., Batard, C., Cahn-Sellem, F., Elbez, A., Wollner, A., Romain, O., Corrard, F., et al. (2020) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2020-000887 · Cited by 33
Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2Preprint
Yang, X., Dai, T., Zhou, X., et al. (2020) · medRxiv · doi:10.1101/2020.03.23.20040675 · Cited by 32
(2020) · doi:10.1101/2020.06.08.138826 · Cited by 31
Antibody Profiling of COVID-19 Patients in an Urban Low-Incidence Region in Northern Germany
Solbach, W., Schiffner, J., Backhaus, I., Burger, D., Staiger, R., Tiemer, B., Bobrowski, A., Hutchings, T., & Mischnik, A. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.570543 · Cited by 30
Utility of lateral flow tests in SARS-CoV-2 infection monitorization
Candel, F. J., Viñuela-Prieto, J. M., del Castillo, J. M. G., García, P. B., Saavedra, M. F., Píriz, A. H., Virumbrales, D. J., Canora, J., Sánchez, G. G. D. C., Prieto, R. G., et al. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/052.2020 · Cited by 29
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasmaPreprint
Soler, L. F., Daguer, J., Barluenga, S., Cohen, P., Pagano, S., Yerly, S., Kaiser, L., Vuilleumier, N., & Winssinger, N. (2020) · medRxiv · doi:10.1101/2020.06.15.20131391 · Cited by 29
Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
Jungbauer, C., Weseslindtner, L., Weidner, L., Gänsdorfer, S., Farcet, M. R., Reichhart, E., & Kreil, T. R. (2020) · Transfusion · doi:10.1111/trf.16119 · Cited by 29
Danh, K., Karp, D. G., Singhal, M., Tankasala, A., Gebhart, D., Cortez, F. D. J., Tandel, D., Robinson, P. V., Seftel, D., Stone, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31796-1 · Cited by 28
SARS-CoV-2 serology: Test, test, test, but interpret with caution!
Bermingham, W. H., Wilding, T., Beck, S. C., & Huissoon, A. P. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0170 · Cited by 27
Self-citationKwan, S. T., Presswood, B. H., Helfrich, K. K., Baulch, J. W., Mooney, S. M., & Smith, S. M. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00320-9 · Cited by 26
Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infectionPreprint
Borremans, B., Gamble, A., Prager, K. C., Helman, S. K., McClain, A. M., Cox, C., Savage, V. M., & Lloyd‐Smith, J. O. (2020) · medRxiv · doi:10.1101/2020.05.15.20103275 · Cited by 25
Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.096511 · Cited by 23
IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunityPreprint
Ejemel, M., Li, Q., Hou, S., Schiller, Z. A., Wallace, A., Amcheslavsky, A., Yılmaz, N. K., Toomey, J. R., Schneider, R., Close, B. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.15.096719 · Cited by 22
Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19Preprint
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M. E., Yang, L., Sivapatham, S., Jacobs, A., Bächli, E., Rudiger, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.04.236521 · Cited by 22
Comparison and application of different immunoassay methods for the detection of SARS‐CoV‐2
He, J., Hu, P., Gao, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26187 · Cited by 21
Ou, J., Tan, M., He, H., Tan, H., Mai, J., Long, Y., Jiang, X., He, Q., Huang, Y., Li, Y., et al. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab003 · Cited by 21
Thieme, C. J., Anft, M., Paniskaki, K., Blazquez‐Navarro, A., Doevelaar, A. A. N., Seibert, F. S., Hölzer, B., Konik, M., Brenner, T., Tempfer, C. M., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3606763 · Cited by 18
Gniffke, E. P., Harrington, W. E., Dambrauskas, N., Jiang, Y., Trakhimets, O., Vigdorovich, V. I., Frenkel, L. M., Sather, D. N., & Smith, S. E. P. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa508 · Cited by 17
Buntinx, F., Claes, P. D., Gulikers, M., Verbakel, J. Y. J., Lepeleire, J. D., der Elst, M. V., Elslande, J. V., Ranst, M. A. V., & Vermeersch, P. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1834285 · Cited by 17
The Production and Clinical Implications of SARS-CoV-2 AntibodiesPreprint
Hu, Q., Cui, X., Liu, X., Peng, B., Jiang, J., Wang, X., Li, Y., Hu, W., Ao, Z., Duan, J., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3576845 · Cited by 15
Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19Preprint
Juno, J. A., Tan, H., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K. M., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · medRxiv · doi:10.1101/2020.05.17.20104869 · Cited by 15
Liu, Q., Fang, X., Tokuno, S., Chung, U., Chen, X., Dai, X., Liu, X., Xu, F., Wang, B., & Peng, P. (2020) · medRxiv · doi:10.1101/2020.04.06.20056127 · Cited by 14
COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce
Favara, D. M., Cooke, A., Döffinger, R., Houghton, S., Budriunaite, I., Bossingham, S., McAdam, K., Corrie, P. G., & Ainsworth, N. L. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.07.015 · Cited by 14
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infectionPreprint
Ozturk, T. T., Howell, C., Benameur, K., Ramonell, R. P., Cashman, K. S., Pirmohammed, S., Bassit, L., Roback, J. D., Marconi, V. C., Schinazi, R. F., et al. (2020) · medRxiv · doi:10.1101/2020.05.10.20097535 · Cited by 13
Duan, L., Zhang, S., Guo, M., Zhou, E., Fan, J., Wang, X., Wang, L., Wu, F., & Jin, Y. (2020) · medRxiv · doi:10.1101/2020.06.18.20134619 · Cited by 12
Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)
Dong, X., Wang, M., Liu, S., Zhu, J., Xu, Y., Cao, H., & Li, L. (2020) · Aging and Disease · doi:10.14336/ad.2020.0317 · Cited by 10
Lou, Y., Zhao, W., Wei, H., Chu, M. G., Chao, R., Yao, H., Su, J., Li, Y., Li, X., Cao, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.06.137513 · Cited by 9
Dobi, A., Frumence, É., Rakoto, M. L., Lebeau, G., Vagner, D., Anne-Laure, S. S., Giry, C., Septembre‐Malaterre, A., Jaffar‐Bandjee, M., Raffray, L., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123847 · Cited by 8
Bwire, G. M., & Njiro, B. J. (2020) · medRxiv · doi:10.1101/2020.06.09.20127118 · Cited by 4
Cited by
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Stein, C., Nassereldine, H., Sorensen, R. J. D., Amlag, J. O., Bisignano, C., Byrne, S., Castro, E., Coberly, K., Collins, J. K., Dalos, J., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02465-5 · Cited by 412
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244126 · Cited by 374
Self-citationCorrelates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 298
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Chen, X., Chen, Z., Azman, A. S., Deng, X., Sun, R., Zhao, Z., Zheng, N., Chen, X., Lu, W., Zhuang, T., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00026-7 · Cited by 239
Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays
Dimech, W., Curley, S., Subissi, L., Ströher, U., Perkins, M. D., & Cunningham, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05101-22 · Cited by 4
Metadata
- Authors
- Shrotri, M., van Schalkwyk, M. C. I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., Maher, J., Shields, A. M., Amirthalingam, G., Peacock, S. J., & Ismail, S. A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-01-25
- Volume
- 16
- Issue
- 1
- Pages
- e0245532
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W3115281787
- Cited by
- 350
- References
- 251
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.